portfolio detail Glygenix Therapeutics

Glygenix Therapeutics

GlyGenix Therapeutics is focused on treating and curing Glycogen Storage Diseases (GSDs). The company’s primary focus is curing GSD type 1a, which is caused by an inherited gene mutation resulting in altered glycogen metabolism and glucose homeostasis.

CI Representative:
Patrick O’Neill
Director, Investments

back to portfolio